Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced that the European Medicines Agency's Committee for Orphan Medicinal Products has adopted a positive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE